BOPW
NAGE

Brandywine Oak Private Wealth’s Niagen Bioscience NAGE Stock Holding History

Brandywine Oak Private Wealth’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-300
Closed -$1K – 662
2018
Q4 		$1K Buy
+300
New +$1.04K ﹤0.01% 697

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Brandywine Oak Private Wealth's NAGE Position: Q1 2019 in Review

Brandywine Oak Private Wealth sold out of Niagen Bioscience (NAGE) in Q1 2019, closing a stake of 300 shares — an estimated $1K sold.

Brandywine Oak Private Wealth first reported a position in NAGE in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 58 funds tracked by Wall St. Rank hold NAGE as of Q1 2019.

  • Brandywine Oak Private Wealth reported no remaining Niagen Bioscience position as of Q1 2019 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 300 Niagen Bioscience shares in Q1 2019, an estimated $1K.
  • Brandywine Oak Private Wealth first reported a position in Niagen Bioscience in Q4 2018 and held it in 1 quarter.
  • Brandywine Oak Private Wealth's Niagen Bioscience position peaked at $1K in Q4 2018.
  • 58 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2019.

Based on Brandywine Oak Private Wealth's 13F filing for Q1 2019, filed 9 May 2019.